跳转至内容
Merck
CN
  • Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.

Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.

STAR protocols (2020-12-31)
Veronika Sander, Aneta Przepiorski, Amanda E Crunk, Neil A Hukriede, Teresa M Holm, Alan J Davidson
摘要

Kidney organoids represent a physiologically advanced model for studying the mechanisms of kidney development and disease. Here, we describe a simple two-step protocol for the differentiation of human pluripotent stem cells into kidney organoids. Our approach involves suspension culture that allows for rapid and cost-effective bulk production of organoids, which is well suited for large-scale assays such as drug screening. The organoids correspond to fetal human kidney tissue and may be of limited use for modeling adult kidney function. For complete details on the use and execution of this protocol, please refer to Przepiorski et al. (2018).

材料
货号
品牌
产品描述

Sigma-Aldrich
二甲苯, histological grade
Sigma-Aldrich
柠檬酸钠二水合物, ≥99%, FG
Sigma-Aldrich
氯化钠, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
聚乙烯醇, 87-90% hydrolyzed, average mol wt 30,000-70,000
Sigma-Aldrich
抗 HNF1B 兔抗, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
抗 钙结合蛋白-D-28K (EG-20) 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗-EPCAM 兔抗, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-SLC12A1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution